BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$41.98
−1.66%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$43.14
From 52W high−60.01%
Volume22.05M
Market cap$60.84B
P/E (TTM)17.7x
P/S (TTM)2.9x
Div yield—
Key dataOct 30, 2026
Open
$43.14
From 52W high
−60.01%
Volume
22.05M
Market cap
$60.84B
ValuationView details →
P/E (Fwd)
13.2x
EV/EBITDA
—
P/E (TTM)
17.7x
RSI (14)
42.0
MomentumView details →
1D Return
−1.66%
YTD Return
−55.17%
SummaryUpdated Sep 1, 2026
Boston Scientific Corporation (NYSE:BSX) is a leading global medical device company founded in 1979 and headquartered in Marlborough, Massachusetts. The company went public in 1992 and has since grown to become one of the world's largest medical technology companies, developing, manufacturing, and marketing medical devices used in various interventional medical specialties worldwide. Boston Scientific operates through three primary segments and has established itself as a major player in the medical device industry through both organic growth and strategic acquisitions.
Similar companies
Latest newsMore news →
BOSTON SCIENTIFIC CORP introduced a new operating model to improve the accuracy of future performance forecasts.3d agoBOSTON SCIENTIFIC CORP reported third-quarter revenue of $5.14 billion, up 1.4%, and adjusted earnings per share of $0.73, in line with expectations.3d agoBOSTON SCIENTIFIC CORP shares fell 7.55% to $41.66.3d ago